Fig. 2 (abstract O22).From: 32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part OneHigh sMIC induces colitis in response to anti-CTLA4 therapyBack to article page
